Drug target screening in cancer involves the identification of specific molecules or pathways that play a crucial role in the growth, survival, and spread of cancer cells. These targets can be proteins, genes, or signaling pathways that, when inhibited or modulated, can potentially lead to therapeutic benefits. The process typically begins with a comprehensive understanding of the cancer's molecular biology, followed by the identification of potential targets through various techniques.
